Berit Seljelid

PhD candidate



+47 91153252

Current positions

  • PhD candidate


  • Ph.D Programme. Faculty of Medicine, University of Oslo
  • Post Graduate Programme in Evidence based Practice (2011), Bergen University College  
  • Master in Science (2008), Akershus University College
  • Post Graduate Programme in Health Pedagogics (2007), Akershus University College
  • Bachelor in nursing (1999), Oslo University College
  • One-year foundation level in psychology (1995), University of Trondheim
  • Examen philosophicum (1994), University of Trondheim

Research/Clinical Interests

  • eHealth
  • Patient- health care provider communication, relationship and interaction 
  • Shared Decision Making
  • Health Literacy
  • Implementation of eHealth interventions
  • Stakeholder Involvement


  • Registered Nurse (1999)


  • Department of Nephrology, Oslo University Hospital
  • Section of Specialized Endocrinology, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Division of Medicine, Oslo University Hospital


Publications 2022

Seljelid B, Varsi C, Solberg Nes L, Øystese KA, Børøsund E (2022)
Feasibility of a Digital Patient-Provider Communication Intervention to Support Shared Decision-Making in Chronic Health Care, InvolveMe: Pilot Study
JMIR Form Res, 6 (4), e34738
DOI 10.2196/34738, PubMed 35389356

Publications 2021

Seljelid B, Varsi C, Solberg Nes L, Øystese KA, Børøsund E (2021)
A Digital Patient-Provider Communication Intervention (InvolveMe): Qualitative Study on the Implementation Preparation Based on Identified Facilitators and Barriers
J Med Internet Res, 23 (4), e22399
DOI 10.2196/22399, PubMed 33830063

Publications 2020

Seljelid B, Varsi C, Solberg Nes L, Stenehjem AE, Bollerslev J, Børøsund E (2020)
Content and system development of a digital patient-provider communication tool to support shared decision making in chronic health care: InvolveMe
BMC Med Inform Decis Mak, 20 (1), 46
DOI 10.1186/s12911-020-1065-8, PubMed 32131808

My projects

Involve me

eHealth solutions for patients with non functioning pituitary adenomas and patients receiving renal replacement therapy